Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Diabetes mellitus (BASKET).php on line 2
Diabetes mellitus (BASKET)
LE WE PMID CA
Diabetes mellitus (BASKET)663Diabetes mellitus (allg)

3 deoxyglucosone

Autoantibodies Anti CD38

beta cell (Pancreas)

Cadmium

Carbonyl stress

Cystic fibrosis

Diabetes mellitus (BASKET)

Diabetes mellitus (Dermatology)

Diabetes mellitus (Involvement kidney)

Endothelial dysfunction

ERS UFR (Diseases)

ERS UFR (Induced Mediators)

Fatty acids (Free)

GADD153 CHOP

Glyoxal

Histone deacetylase

Inflammation (BASKET)

Ketoacidosis

Kidney (Podocytes)

Kidney (Toxicology)

Lipid lowering compounds

Lipotoxicity

Maillard reaction

MCP1 Monocyte chemotactic protein1

Methylglyoxal

Nitrosative stress

Obesity (BASKET)

Orlistat

Palmitate

Pancreas (Anatomy)

Paradontosis

PARP

Protein kinase B Akt

RAAS (Angiotensin converting enzyme 2)

Receptor (Free fatty acids)

Redox (BASKET)

TNF alpha

TRB3

Vanadium

2002  
1
Chronic complications of diabetes.
[11829013] South Med J 95(1): 30-4 (2002)
2008  
2
A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus.
[18319296] QJM 101(5): 351-8 (2008)
2006  
3
Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.
[16990690] Neth J Med 64(8): 269-79 (2006)
2008  
4
2009  
5
Angiotensin blockade to reduce microvascular damage in diabetes mellitus.
[19795011] Dtsch Arztebl Int 106(34-35): 556-62 (2009)
2008  
6
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.
[18827908] Vasc Health Risk Manag 4(3): 575-96 (2008)
2008  
7
Orlistat in the prevention of diabetes in the obese patient.
[18561508] Vasc Health Risk Manag 4(2): 325-36 (2008)
1960  
8
Methods of studying antidiabetic substances--a review.
[14446231] Indian J Physiol Pharmacol 4(-): 1-16 (1960)
2009  
9
Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus?
[20011163] Can J Surg 52(6): E269-75 (2009)
1998  
10
A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?
[9605655] Ann Surg 227(5): 637-43; discussion 643-4 (1998)
2003  
11
Guidelines for the detection of diabetes mellitus--diagnostic criteria and rationale for screening.
[18568047] Clin Biochem Rev 24(3): 77-80 (2003)
2003  
12
Treatment of diabetic ketoacidosis in children and adolescents.
[14509913] Acta Biomed 74(2): 59-68 (2003)
2002  
13
Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment.
[11991790] Altern Med Rev 7(2): 94-111 (2002)
2010  
14
Autophagy in health and disease. 4. The role of pancreatic beta-cell autophagy in health and diabetes.
[20457840] Am J Physiol Cell Physiol 299(1): C1-6 (2010)
2008  
15
Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: pharmacological, phylogenetic, and drug discovery aspects.
[18385136] J Biol Chem 283(24): 16269-73 (2008)
2008  
16
Glucolipotoxicity: fuel excess and beta-cell dysfunction.
[18048763] Endocr Rev 29(3): 351-66 (2008)
2005  
17
Regulation of pancreatic beta-cell mass.
[16183912] Physiol Rev 85(4): 1255-70 (2005)
2002  
18
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.
[11861436] Clin Chem 48(3): 436-72 (2002)
2005  
19
Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.
[16356120] Antioxid Redox Signal 7(11-12): 1568-80 (2005)
2007  
20
The use of oral antidiabetic agents in primary care.
[17565410] Aust Fam Physician 36(6): 477-80 (2007)
2010  
21
Diabetes mellitus classification.
[20857049] Arq Bras Cardiol 95(2): e40-6 (2010)
2009  
22
The sweeter side of ACE2: physiological evidence for a role in diabetes.
[18948167] Mol Cell Endocrinol 302(2): 193-202 (2009)
2010  
23
Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus.
[20634940] Mediators Inflamm 2010(-): 792393 (2010)
2010  
24
Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis.
[20182627] Mediators Inflamm 2010(-): 453892 (2010)
2011  
25
Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.
[21274504] Mol Med 17(5-6): 378-90 (2011)
2010  
26
The role of epigenetics in the pathology of diabetic complications.
[20462972] Am J Physiol Renal Physiol 299(1): F14-25 (2010)
2005  
27
Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications.
[15717836] Physiol Res 54(1): 1-16 (2005)
2010  
28
Glycotoxines, carbonyl stress and relevance to diabetes and its complications.
[19537931] Physiol Res 59(2): 147-56 (2010)
2005  
29
Surgery as an effective early intervention for diabesity: why the reluctance?
[15677819] Diabetes Care 28(2): 472-4 (2005)
2003  
30
Implications of the diabetes control and complications trial.
[12502616] Diabetes Care 26 Suppl 1(-): S25-7 (2003)
2003  
31
Implications of the United kingdom prospective diabetes study.
[12502617] Diabetes Care 26 Suppl 1(-): S28-32 (2003)
2003  
32
Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications.
[12502619] Diabetes Care 26 Suppl 1(-): S51-61 (2003)
2010  
33
Diagnosis and classification of diabetes mellitus.
[20042775] Diabetes Care 33 Suppl 1(): S62-9 (2010)
2010  
34
Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis.
[20103557] Diabetes Care 33(2): 421-7 (2010)
2007  
35
2007  
36
Microvascular complications in cystic fibrosis-related diabetes.
[17322485] Diabetes Care 30(5): 1056-61 (2007)
2009  
37
Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14,664 patients from 106 institutions.
[19549730] Diabetes Care 32(9): 1647-8 (2009)
2008  
38
Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis.
[18227499] Diabetes Care 31 Suppl 2(-): S290-6 (2008)
2011  
39
Lipid-induced pancreatic beta-cell dysfunction: focus on in vivo studies.
[21119027] Am J Physiol Endocrinol Metab 300(2): E255-62 (2011)
2010  
40
TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1.
[20660016] Am J Physiol Renal Physiol 299(5): F965-72 (2010)
2009  
41
Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: is there a role for adipose tissue and liver?
[19757063] Apoptosis 14(12): 1424-34 (2009)
2010  
42
Diabetes and inflammation: fundamental aspects and clinical implications.
[20851652] Diabetes Metab 36(5): 327-38 (2010)
2010  
43
Development and psychometric properties of the 12-item diabetes fatalism scale.
[19908102] J Gen Intern Med 25(1): 61-6 (2010)
2005  
44
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
[15723618] Curr Med Chem 12(3): 267-75 (2005)
2008  
45
Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.
[18752069] Rev Endocr Metab Disord 9(4): 275-87 (2008)
2005  
46
B cells in autoimmune diabetes.
[17491687] Rev Diabet Stud 2(3): 121-35 (2005)
2007  
47
TNFalpha in the pathogenesis of diabetes-induced embryopathies: functions and targets.
[18338073] Rev Diabet Stud 4(4): 200-9 (2007)
2005  
48
Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies.
[16304446] J Dent Res 84(12): 1154-9 (2005)
2010  
49
Management of hypertriglyceridemia in the diabetic patient.
[20532703] Curr Diab Rep 10(4): 316-20 (2010)
2003  
50
Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes.
[15061645] Exp Diabesity Res 4(3): 169-82 (2003)
2006  
51
Anti-CD38 autoantibodies in type? diabetes.
[16544364] Diabetes Metab Res Rev 22(4): 284-94 (2006)
2011  
52
The prediabetic period: review of clinical aspects.
[21738892] Diabetes Metab J 35(2): 107-16 (2011)
2008  
53
Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities.
[19040593] J Cardiometab Syndr 3(4): 234-43 (2008)
2009  
54
Cadmium, diabetes and chronic kidney disease.
[19327375] Toxicol Appl Pharmacol 238(3): 289-93 (2009)
2010  
55
Epigenetics: mechanisms and implications for diabetic complications.
[21148447] Circ Res 107(12): 1403-13 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Diabetes mellitus (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Diabetes mellitus (BASKET).php on line 92